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We read with interest the article on the ACS registry in
Himachal Pradesh.1 In this registry only 38% of patients received
thrombolysis and only 0.9% received primary angioplasty for
STEMI. The median door to needle time was 760 min. But this was a
multicentre multihospital study, including rural and urban centres
and hospitals with a long transit time, and there appears to have
only two medical colleges in the whole cohort. So it is
commendable that they have systematically analysed their results
and published them.
The second study describing primary angioplasty in India was
the study from Guwahati that has studied more than 700 patients
over a 2-year period. Here only 36% of 510 STEMI patients received
thrombolytic therapy and the door to balloon time was around 9 h.
This is also dismally long.2 As commented patient education by
massive television campaigns would help patients report early.
I would like to point out an encouraging trend seen in our
centre. If you take for example this last Sunday, we had 4 STEMIFig. 1. The different intervals related to delay in time to performing a PCI or thrombol
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thrombolysis. We are of course forced to thrombolyse patients
without insurance, or when the cath-lab is busy.
The prevalence of coronary artery disease in India is the highest
in Kerala.3 Kerala is a small state that forms the southern most
aspect of India. Previous data from India have revealed that
after the diagnosis of myocardial infarction is made only 17% of
patients in Kerala have insurance.4,5 But here we have studied a
small cross section of Kerala patients presenting to a tertiary
hospital for acute myocardial infarction for a 6 month period in
2014 (August 2014 to January 2015).
The total number of patients was 286. The mean age of the
patients was 56.2  11.7 years. There were 244 males and
42 females. We analysed the different intervals related to delay
in treating the patient (not included in this letter). We broke up
these delays into various intervals (not included in this letter)
(Fig. 1). Of these 65.7% underwent primary angioplasty and
thrombolysis with intravenous streptokinase was given in 34.3%
of patients (Fig. 2).
We have found that 68.1% of patients have a government
insurance where the premium paid by the patient is very low
(Rs 500/year). This covers the entire family, and gives a coverage of
Rs 70,000 per year. This scheme is called the RSBY. We found that
68.1% of the patients willing for primary angioplasty were covered
by this scheme. So in 2015 this government initiated insurance has
helped many patients. This is specially gratifying in view of the
report from our sister institution.4 They have reported in 2012 that
average expenditure of a patient diagnosed with coronary artery
disease was approximately Rs 105,023, total expenditure duringysis.
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Fig. 2. The diagram showing the percentage of patients opting for primary
angioplasty in a cohort of patients seen between 2014 August and January 2015.
Fig. 3. The percentage of patients who had insurance for performance of primary
angioplasty.
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and taking loans that cripple the patients or their families.
The Kerala government has sponsored a patient treatment
scheme called Karunya benevolent fund (The money is collected by
online lottery collections). This is for patients with known coronary
lesions, who subsequently get their money sanctioned and are
funded for coronary angioplasty and stenting. In our small cohort,
1.6% of patients have been funded for primary coronaryangioplasty from this scheme. 30.3% of patients paid the expenses
from their own pockets (Fig. 3).
We also had a short in hospital delay of (59.5.5 min), our total
ischaemic period was 235 min. It was 227.2  118 min for the
thrombolysed patients and was 239.  _min in the primary PCI
patients. This is very much less than the total ischaemic period of
360 min reported in the Kerala ACS registry.5 From 2012 the situation
seems to have improved to a large extent.
We believe this shows that the scenario has improved in Kerala
in recent times.
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